3-Phenoxybenzaldehyde
C1s-IN-1
N-((Allyloxy)carbonyl)-N-methyl-L-alanine
Crovalimab
Olendalizumab
Pexelizumab
Pozelimab
Gefurulimab
Gavilimomab
Avdoralimab
Vilobelimab
Lampalizumab
Ravulizumab
Tesidolumab
Vesencumab
Eculizumab
Sutimlimab
Empasiprubart
Riliprubart
C5a Receptor agonist, W5Cha